Recombinant Anti-CD3 x Anti-MUC1 Bispecific Antibody (Triple Body) is designed to be expressed as two polypeptide chains respectively. The Fd fragment and LC from an anti-CD3 antibody are both extended with the scFv fragment from an anti-MUC1 antibody. This BsAb can retarget T cells to tumor cells. It is designed for the research of Pancreatic cancer; Ovarian cancer; Breast cancer; Bile duct cancer (BDC) therapy.
There are currently no customer reviews or questions for Recombinant Human Anti-CD3 x Anti-MUC1 Bispecific Antibody (Triple Body) (TRIB-H271). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS